A phase 1 trial of BLU-5937 for chronic cough

Next Previous
Trial Profile

A phase 1 trial of BLU-5937 for chronic cough

Planning
Phase of Trial: Phase I

Latest Information Update: 21 Feb 2018

At a glance

  • Drugs BLU-5937 (Primary)
  • Indications Cough
  • Focus Adverse reactions

    • Most Recent Events

    • 21 Feb 2018 According to a BELLUS Health media release, company expects to start this trial in third quarter of 2018 and expects top line data by year-end.
    • 08 Nov 2017 According to a BELLUS Health media release, the company is planning file a Clinical Trial Application in the second quarter of 2018 and initiate this trial in the third quarter of 2018.
    • 11 Aug 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top